Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 31.18% is 140% above its 5-year average of 12.99%, near the high end of its 5-year range (0.00%–31.82%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.91% above its 12-month average of 28.12%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 31.18%.
DEBT TO ASSETS RATIO
31.18%
DEBT TO ASSETS RATIO AVG TTM
28.12%
DEBT TO ASSETS RATIO AVG 3Y
20.55%
DEBT TO ASSETS RATIO AVG 5Y
12.99%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+10.91%
CURRENT VS 3Y AVG
+51.73%
CURRENT VS 5Y AVG
+140.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
+31083.51%
vs the sector median at left
Biofrontera Inc.
Market Cap
$11.38M
Debt to Assets Ratio
31.18%
TTM Avg
28.12%
3Y Avg
20.55%
5Y Avg
12.99%
Market Cap
$11.24M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.30M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.21M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.93M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.73M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$11.78M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.38M | 31.18% | 28.12% | 20.55% | 12.99% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.24M | 0.06% | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | 0.01% | N/A | N/A | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | 0.00% | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.16M | 0.02% | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.94M | 0.00% | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | 0.00% | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.73M | 0.00% | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.78M | 0.01% | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.49M | 0.32% | N/A | N/A | N/A |
Debt/Assets
31.2%
Debt/Equity
1.26
Current Ratio
1.18
Interest Coverage
-20.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 31.18% |
| 2026-03-31 | 31.16% |
| 2025-12-31 | 21.57% |
| 2025-09-30 | 31.82% |
| 2025-06-30 | 24.84% |
| 2025-03-31 | 29.32% |
| 2024-12-31 | 22.27% |
| 2024-09-30 | 5.37% |
| 2024-06-30 | 6.67% |
| 2024-03-31 | 29.44% |
| 2023-12-31 | 19.33% |
| 2023-09-30 | 8.25% |
| 2023-06-30 | 5.95% |
| 2023-03-31 | 2.88% |
| 2022-12-31 | 2.65% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
